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Introduction. Malnutrition accompanies many cancers, especially those of the gastrointestinal tract, and significantly 
raises the risk of postoperative complications in cancer surgery. In Poland, hospitals are legally obliged to evaluate 
the nutritional status of their patients; one of the assessment tools used for this purpose is the NRS 2002 scale. 
Aim. The primary objective of the study is to analyze the utility of the NRS 2002 scale in the risk assessment of posto-
perative complications in gastrointestinal cancers. In addition, the authors propose to determine whether the legal 
requirement to conduct nutritional assessments among hospitalized patients is complied with in clinical practice 
and to evaluate the risk of malnutrition in the study group. 
Materials and methods. A detailed assessment was conducted on 226 patients who underwent surgery for upper 
(95 patients) and lower (131 patients) GI tract cancers in 2015. The risk of complications was analyzed based on the 
nutritional risk score (NRS 2002) and the levels of albumin and total proteins in the serum before surgery. Compliance 
with the obligation to carry out nutritional assessments was evaluated on breast and GI cancer patients treated with 
surgery at the Institute of Oncology in Warsaw in two successive years. 
Results. An NRS 2002 score of ≥ 3 was shown to predict postoperative complications for both upper GI tract (p < 0.001) 
and colorectal cancers (p < 0.001). In upper GI cancers, complications were also more frequently observed at lower 
albumin (p = 0.018) and total protein (p = 0.025) levels in the serum.
Conclusion. The analysis shows that the NRS 2002 scale is useful in predicting the risk of postoperative complications 
in the treatment of upper and lower GI tract cancers.
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Introduction
Malnutrition accompanies many cancers, especially tho-
se of the gastrointestinal tract, and is not only one of the 
early symptoms of disease, but also the direct consequence 
of the condition and its treatment. Its causes include the 
loss of appetite, reduced food intake, metabolic changes 
due to the tumor and cancer-related chronic inflammation, 
as well as the side effects of cancer treatment, including 
surgery and chemo- and radiotherapy. In operated patients 
with GI cancers, malnutrition is an independent risk factor 
for an increased incidence of complications, nosocomial 
infections, and perioperative mortality [1–6].
As of 1 January 2012, in accordance with the Ordinance 
of the Minister of Health of 15 September 2011, amended 
on 22 November 2013, Polish hospitals are obliged to carry 
out an assessment of the nutritional status of patients ad-
mitted to all their wards, including emergency rooms. For 
this purpose, they can use either of the following tools: the 
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Subjective Global Assessment scale (SGA) or the Nutritional 
Risk Screening scale (NRS 2002). The simpler of the two, NRS 
2002 (Annex 1), evaluates the degree to which the patient’s 
nutritional status has deteriorated, including indicators such 
as the loss of body mass over three months, the BMI, food 
intake as a proportion of the daily requirement over the 
previous week, as well as the severity of the disease, which 
tends to be accompanied by an increased demand for nu-
trients. An additional risk factor for malnutrition is age above 
70 years. On a scale from 0 to 7, a score of ≥ 3 indicates that 
nutritional therapy should be introduced [7].
Purpose
The primary objective of the study was to analyze the 
utility of the NRS 2002 scale in the risk assessment of posto-
perative complications in gastrointestinal cancers. In addi-
tion, the authors proposed to determine whether the legal 
requirement to conduct nutritional assessments among 
hospitalized patients is complied with in clinical practice 
and to evaluate the risk of malnutrition in the study group.
Materials and methods
In order to determine how often the NRS 2002 scale is 
completed and assess the risk of malnutrition among cancer 
patients, the study evaluated surgical units and clinical onco-
logy wards in two different clinics of the Marie Skłodowska-
-Curie Cancer Centre and Institute of Oncology in Warsaw: 
the Clinic of Breast Cancer and Reconstructive Surgery (KNPi-
ChR) and the Clinic of Oncological Gastroenterology (KGO). 
The assessment was conducted in 2014 and 2015. Over the 
studied period, the KNPiCHR performed surgery on 3,420 
patients and administered conservative treatment to 16,744, 
while the corresponding figures for the KGO were 1,888 and 
4,054, respectively. The exact distribution of admissions to 
specific wards is shown in Table I. The choice of clinics was 
dictated by the difference in nutritional risk in breast and 
gastrointestinal cancers. 
A detailed assessment of the prognostic utility of the 
NRS 2002 scale was conducted on 226 patients with eso-
phagus, stomach, colon, and rectum cancers who were ope-
rated on in 2015. The study group consisted of 76 women 
(34%) and 150 men (66%); the median age was 59 (29–85) 
years. The exact distribution of diagnosis, gender, and age 
is shown in Table II. Alongside the NRS 2002 scale, the risk 
of malnutrition was also assessed based on albumin (ALB) 
and total protein (TP) levels in the serum, as measured a day 
before surgery. The threshold level for the NRS 2002 scale 
was defined as a score of 3 or more, and for ALB and TP — as 
35 mg% and 66 mg%, respectively.
All patients were prepared for surgery in the same man-
ner, receiving special pre-operative nutritional treatment 
whenever their weight loss exceeded 10%/3 months, as well 
as undergoing anithrombotic prophylaxis and perioperative 
antibiotic therapy. 
Data about surgical complications were gleaned from 
the prospective database of postoperative events kept at 
the Gastroenterology Clinic since 2010. These included the 
formation of abscesses at the surgical site, abdominal and 
scrotal wound infections, post-operative bleeding, anasto-
motic leaks, obstruction, UTIs, wound dehiscence, and other 
adverse symptoms, such as diarrhoea, rectovaginal fistulas, 
urinary retention, delayed peristalsis, urinary bladder dys-
functions, and sinus tachycardia.
The data were analyzed with the SPSS 15 statistical pac-
kage; the Fisher’s exact test was used whenever the number 
of cases was ≤ 10, while the chi-square Pearson test was 
employed when the number greater.
Results
The utility of the NRS 2002 scale in nutritional asses-
sment and the risk prognosis of postoperative complications 
was studied on patients with esophagus, stomach, and 
intestinal cancers who underwent surgery in 2015. Due to 
significant differences in the invasiveness of the procedure, 
perioperative risk, and the predicted number of malnouri-
shed patients, upper (esophagus and stomach) and lower 
(colon and rectum) tract cases were analyzed separately. 
The evaluation relied on the NRS 2002 scale, as well as the 
serum levels of albumin and total protein before surgery. 
Table I. Admissions to the Clinic of Breast Cancer and Reconstructive 
Surgery (KNPChR) and the Clinic of Oncological Gastroenterology (KGO)
Clinic/Ward Number of admissions per annum
2014 2015
KNPChR Surgical Ward 1.733 1.687
KNPChR Oncology Ward 11.722 5.022
KGO Surgical Ward 864 1.024
KGO Oncology Ward 1.681 2.372
Table II. Characteristics of the study group: patient diagnosis (ICD 10), age, and sex
Diagnosis Number of patients
(n)
Median age
(range)
Sex
Women n (%) Men n (%)
C15–16 95 58 (29–80) 30 (32%) 65 (68%)
C18–19 65 59 (41–85) 26 (40%) 39 (60%)
C 20 66 56 (39–79) 20 (30.3%) 46 (69.7%)
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In the upper tract group, both the NRS 2002 score (p < 0.001) 
and albumin level (p = 0.018) were identified as a risk factor 
for postoperative complications; the latter were observed 
in 31 patients (33%), and mostly included septic symptoms 
— 10 (10%) and respiratory failure — 9 (9%). Detailed infor-
mation can be found in Table III. In patients with lower tract 
cancers, only the NRS score (p < 0.001) was shown to have 
predictive utility. Postoperative complications, mostly septic 
(15 people, i.e. 11%), were observed in 34 patients (18%). 
Detailed data are shown in Table IV.
The analysis showed that head physicians largely failed 
to comply with the obligation of nutritional assessment. 
Compliance rates were higher in surgical departments: 
at the surgical ward of the KNPiChR, 63% (1,087/1,733) 
of admitted patients underwent assessment in 2014, as 
compared to 94% (1,583/1,687) a year later. In the analyzed 
period, the clinical oncology ward of the clinic used the 
NRS scale to evaluate as few as 5% (913/17,722) and 22% 
(1,088/5,022) of patients, respectively (Fig. 1). The corre-
sponding figures for the surgical ward of the KGO were 63% 
(541/864) and 83% (845/1,024). Nutritional assessment was 
also rare at the clinical oncology ward of the KGO: as few as 
8.5% of hospitalized patients (144/1,681) were evaluated 
in 2014 and the figure further dropped to 8% (190/2,372) 
the following year (Fig. 2).
In order to evaluate the reliability of collected data, 
as compared to the proportion of malnourished patients 
predicted on the basis of available literature, the authors 
also performed an analysis of NRS scores obtained during 
the nutritional assessment conducted in the surgical wards 
of the two clinics in 2015. Due to the scarcity of data from 
clinical oncology units, a similar analysis could not be perfor-
med for patients undergoing conservative treatment. At the 
KNPiChR, 1,535 patients (94%) obtained a score of less than 
3; 92 (6%) scored 3 or more. At the KGO, the corresponding 
values were 419 (49%) and 426 (51%), respectively (Fig. 3).
Discussion
With a significant impact on clinical outcome, malnu-
trition is now considered a major factor of poor prognosis 
Table III. Surgery in stomach cancer patients
Parameter Postoperative 
complications
n (%)
p RR 95% CI
ALB
< 35 (n = 12)
≥ 35 (n = 81)
8 (66.7)
23 (28.4)
0.018 2.35 1.38–3.98
TP
< 66 (n = 33)
≥ 66 (n = 59)
16 (48.5)
15 (25.4)
0.025 1.91 1.09–3.34
NRS 2002
< 3 (n = 64)
≥ 3 (n = 29)
7 (10.9)
24 (82.8)
< 0.001 7.57 3.69–15.52
n — number of patients in the group; ALB — albumins in the serum; TP — total 
protein in the serum; NRS 2002 — nutritional risk score 
Table IV. Surgery in intestinal cancer patients (total)
Parameter Postoperative 
complications
n (%)
p RR 95% CI
ALB
< 35 (n = 20)
≥ 35 (n = 111)
6 (30.0)
28 (25.2)
0.782 1.19 0.57–2.50
TP
< 66 (n = 27)
≥ 66 (n = 99)
6 (22.2)
26 (26.3)
0.805 1.18 0.54–2.58
NRS
< 3 (n = 111)
≥ 3 (n = 20)
18 (16.2)
16 (80.0)
< 0.001 4.93 3.06–7.94
n — number of patients in the group; ALB — albumins in the serum; TP — total 
protein in the serum; NRS 2002 — nutritional risk score 
1,733 1,687 
17,722 
5,022 
1,087 1,583 913 1,088 
Surgical Ward 2014 Surgical Ward 2015 Oncology Ward 2014 Oncology Ward 2015
Total admissions NRS 2002 assessment
Figure 1. Nutritional assessment and the number of admissions to the Clinic of Breast Cancer and Reconstructive Surgery (KNPChR)
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in cancer therapy. Relatively frequent, the phenomenon 
occurs in 20–60% of cancer patients [1–3] and may con-
siderably affect the quality of life and treatment results 
[8]; everyone, including those treated in highly developed 
countries of the European Union [9], is at risk. Importantly, 
malnutrition requires longer hospital stays, and, as a conse-
quence, a more lengthy and expensive treatment process 
[4, 10–13], which may take up to twice as long as in properly 
nourished patients with the same diagnosis [2]. Its impact on 
postoperative events in digestive tract surgeries has been 
investigated by numerous clinical studies [3–6]. Associated 
complications may include slower, abnormal wound healing 
and often require the postponement of combined therapy, 
which negatively affects the final outcome of therapy [13]. 
The proper identification of high-risk patients and their nu-
tritional treatment may improve clinical outcomes, shorten 
hospitalization time, reduce the frequency of complications, 
and lower perioperative mortality rates [2, 4, 8, 10, 11, 14].
The choice of an appropriate assessment method (i.e. 
one that would be easy to use and have a high predictive 
value) has been the subject of a plethora of studies and 
metaanalyses thus far [4, 5]. The abundance of available 
tools goes to show that no ideal one-size-fits-all solution has 
yet been found [4, 15]. The NRS 2002 scale, recommended 
for use in the mandatory nutritional assessment of Polish 
hospital patients, is one of such instruments. In their me-
taanalysis of 128 randomized clinical trials, Kondrup et al. 
[7] validated the patient- and treatment-related risk factors 
for malnutrition and proposed the NRS scale as a tool for 
their assessment. Its effectiveness has been confirmed by 
a number of studies [5, 7, 16–19]. Budzyński et al. [17], for in-
stance, analyzed annual admissions to a selected full-profile 
864 
1,024 
1,681 
2,372 
541 
845 
144 190 
Surgical Ward 2014 Surgical Ward 2015 Oncology Ward 2014 Oncology Ward 2015
Total admissions NRS 2002 assessment
Figure 2. Nutritional assessment and the number of admissions to the Clinic of Oncological Gastroenterology (KGO)
1,535 
419 
92 
426 
KNPChR KGO
NRS 2002 < 3 NRS 2002 ≥ 3 
Figure 3. Nutritional assessment of surgical patients in the surgical wards of the Clinic of Breast Cancer and Reconstructive Surgery (KNPChR) and 
the Clinic of Oncological Gastroenterology (KGO) in 2015 
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centre (more than 15,000 patients, 20,000 hospitalizations) 
and confirmed the utility of the NRS 2002 in the prognosis 
of both 14- and 30-day readmission (OR, respectively: 2.44, 
p < 0.0001 and 2.37 p < 0.001) and in-hospital mortality 
(OR 13.95, p < 0.001). Schiesser et al. demonstrated that 
screening test scores can be shown to correlate with the 
frequency and severity of abdominal surgery complications, 
and it should be kept in mind that the risk of malnutrition in 
this patient group is particularly high [10]. In an EuroOOPS 
study conducted on 5,051 patients in 27 European broad- 
-profile centres (surgery, internal medicine, oncology), So-
rensen [18] confirmed the utility of NRS in the prognosis of 
postoperative complications. Gou [19], in turn, evaluated 
337 patients who underwent stomach cancer surgery in 
a single center and found that complications were more 
frequently observed in the NRS ≥ 3 group (p < 0.05). A me-
taanalysis of 11 prospective studies performed by Sun et 
al. [5] likewise confirmed the effectiveness of the scale in 
the risk assessment of surgical complications (p < 0.00001) 
and postoperative mortality (p < 0.00001) among patients 
treated with digestive tract surgery; those with a score of 
< 3 were also shown to require shorter hospitalization times 
(p = 0.009) (Tab. V). Similar conclusions can be drawn from 
our analysis of 226 patients with upper and lower digestive 
tract malignancies. The lack of NRS 2002 scores for all pa-
tients (only 83% were studied) may undermine its validity, 
but a comparison with the Polish population [3] shows 
a  similar distribution of malnutrition in the study group 
(51% NRS 2002 ≥ 3 points).
Like many other studies, the current analysis suggests 
that the NRS 2002 scale may be very useful in the risk as-
sessment of postoperative complications and conservative 
cancer treatment [16–19]. It is an extremely simple tool with 
a high predictive value. Even though nutritional assessments 
are now mandated by law, however, the proportion of pa-
tients who do not undergo such evaluation, especially in 
cancer wards, remains high (more than 90%). This is bound 
to cause alarm, since cancer patients are at a particularly 
elevated risk of further malnutrition as a consequence of 
both the disease and its treatment [13]. The year-to-year 
increase in the number of completed NRS 2002 question-
naires, however, offers a glimmer of hope. Current ESPEN 
guidelines recommend that all cancer patients should be 
screened for malnutrition in order to prevent its adverse 
effects prior to cancer treatment [14].
Conclusion
The NRS 2002 scale is a useful tool for the prognosis of 
postoperative complications in the treatment of GI cancers. 
Even though nutritional assessment is now required by law, 
not all patients, especially among those receiving syste-
mic therapy, undergo such evaluation. The proportion of 
malnourished patients in the study group corresponds to 
similar figures available for the Polish population in relevant 
literature, which confirms the reliability of the assessment. 
The utility of the NRS 2002 scale for individual cancers, types 
of surgical procedures, and in systemic therapy requires 
further research in the framework of prospective studies.
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Annex 1. Nutritional Risk Screening (NRS 2002), final screening
Impaired nutritional status Severity of disease, increase in requirements
Score 0 — Absent Normal nutritional status Score 0 — Absent Normal nutritional requirements
Score 1 — Mild Weight loss > 5% in 3 months or food intake 
below 50–75% of normal requirement in 
preceding week
Score 1 — Mild Hip fracture, chronic patients,  
in particular with acute complications:
cirrhosis, COPD, chronic
hemodialysis, diabetes, oncology
Score 2 — Moderate Weight loss > 5% in 2 months or BMI 18.5–20.5 
+ impaired general condition or
food intake 25–60% of normal
requirement in preceding week
Score 2 — Moderate Major abdominal surgery, stroke,
severe pneumonia, hematologic malignancy
Score 3 — Severe Weight loss > 5% in 1 month (> 15% in 
3 months) or BMI < 18.5 + impaired
general condition or food intake 0–25% of 
normal requirement in preceding week in 
preceding week
Score 3 — Severe Head injury, bone marrow
transplantation,  intensive care
patients (APACHE > 10)
Total score ........... Total score ........... 
Age if ≥ 70 years: add 1 to total score above
Total score:  ...........
COPD — chronic obstructive pulmonary disease; BMI — body mass index
